Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.36M | -1.66M | -24.89M | -39.37M | -5.16M |
| Total Depreciation and Amortization | 7.00K | 8.00K | 13.00K | 15.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.00K | -1.01M | 22.07M | 36.14M | -6.00K |
| Change in Net Operating Assets | -116.00K | 968.00K | -313.00K | -212.00K | 857.00K |
| Cash from Operations | -1.56M | -1.69M | -3.12M | -3.43M | -4.29M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 2.81M | -- | -- |
| Cash from Investing | -- | -- | 2.81M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00K | -9.00K | -12.00K | -11.00K | -10.00K |
| Issuance of Common Stock | 0.00 | 1.00K | 0.00 | 5.34M | 50.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 8.00K | 0.00 | -1.00K |
| Cash from Financing | -10.00K | -8.00K | -4.00K | 5.33M | 39.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.57M | -1.69M | -313.00K | 1.90M | -4.25M |
